Abstract | OBJECTIVE: This study examined whether the two polymorphisms of GPX1 (198Pro--> Leu) and TXNRD2 (370Lys-->Arg) contributed alone or in combination, to the risk of gastric cancer development. METHODS: A total of 361 patients with gastric cancer and 363 cancer-free controls were recruited and their genotypes of the two polymorphisms were determined by polymerase chain reaction-based restrictive fragment length polymorphism (PCR-RFLP) method. Odds ratio (OR) and 95% confidence interval (CI) were computed using unconditional logistic regression model. RESULTS: GPX1 and TXNRD2 polymorphisms individually were not associated with the risk of gastric cancer. Gene-gene interaction of GPX1 and TXNRD2 polymorphisms decreased the risk of gastric cancer. Carrying the protective genotype might decrease the risk at 62% (OR = 0.38, 95% CI = 0.26-0.55, P < 0.001) as compared with the risk genotype. CONCLUSION:
|
Authors | Jia Wang, Tong Sun, Ming Yang, Dong-Xin Lin, Wen Tan, Ke-Ji Li, Ying Xiao |
Journal | Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
(Zhonghua Yu Fang Yi Xue Za Zhi)
Vol. 42
Issue 7
Pg. 511-4
(Jul 2008)
ISSN: 0253-9624 [Print] China |
PMID | 19035188
(Publication Type: English Abstract, Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Glutathione Peroxidase
- TXNRD2 protein, human
- Thioredoxin Reductase 2
- Glutathione Peroxidase GPX1
- GPX1 protein, human
|
Topics |
- Alleles
- Case-Control Studies
- Female
- Gene Frequency
- Genetic Predisposition to Disease
- Genotype
- Glutathione Peroxidase
(genetics)
- Humans
- Male
- Middle Aged
- Polymorphism, Single Nucleotide
- Stomach Neoplasms
(genetics)
- Thioredoxin Reductase 2
(genetics)
- Glutathione Peroxidase GPX1
|